//
SPECT and PET in ischemic heart failure
Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults
Risk of Mortality Following Catheter Ablation of Atrial Fibrillation
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines